
speaker
Kenneth Ellenbogen
MD, FHRS
Medicine
Cardiology, Clinical Cardiac Electrophysiology, Internal Medicine
Richmond, Virginia, United States
Chair, Director, Professor
Dr. Ellenbogen's academic, clinical, and research efforts include an interest in newer, more effective ways to perform ablation and to develop methods for ablation of atrial fibrillation. He is involved in the development of new types of pacemakers and exploring the role of pacemakers in treating congestive heart failure and atrial fibrillation. Dr. Ellenbogen has a highly successful record of attracting both public and private funding and has served as principal investigator on over 100 funded grants and contracts. Additionally, Dr. Ellenbogen has served as the Director of Data and Safety Monitoring Boards for a number of national and international clinical trials.
Dr. Ellenbogen has published more than 250 original scientific reports and over 140 book chapters, editorials and review articles. He is the editor or co-editor of five textbooks on cardiac electrophysiology and pacing and has presented over 290 abstracts at major scientific meetings. He serves on the editorial boards of the Journal of the American College of Cardiology, American Heart Journal, Circulation, the Journal of Cardiovascular Electrophysiology, and Heart Rhythm and is a Senior Editor of Heart Rhythm, PACE, and Circulation: Arrhythmias and Electrophysiology. He is also Chairman of the Heart Rhythm Society Board Review Course.
Dr. Ellenbogen has been an invited lecturer and speaker all over the world and has given over 300 talks at major national meetings, including lectures at Harvard Medical School, the University of California at Los Angeles, Yale University School of Medicine, the University of Michigan, and George Washington University. Dr. Ellenbogen was a member of the writing committee for the AHA/ACC/HRS Guidelines Committee for atrial fibrillation, implantation of cardiac rhythm devices, mode selection for pacemakers, programming of defibrillators, and guidelines for left atrial appendage occlusion devices.